Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

An Analysis of Patterns of Distribution of Buprenorphine in the United States using ARCOS, Medicaid, and Medicare Databases

Zhi-Shan Hsu, Justina A. Warnick, Tice R. Harkins, Briana E. Sylvester, Neal K. Bharati, leTausjua B. Eley, Stephanie D. Nichols, Kenneth McCall, View ORCID ProfileBrian J. Piper
doi: https://doi.org/10.1101/2022.08.22.22279092
Zhi-Shan Hsu
1Department of Medical Education, Geisinger Commonwealth School of Medicine, Scranton, PA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Justina A. Warnick
1Department of Medical Education, Geisinger Commonwealth School of Medicine, Scranton, PA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: jwarnick{at}som.geisinger.edu
Tice R. Harkins
1Department of Medical Education, Geisinger Commonwealth School of Medicine, Scranton, PA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Briana E. Sylvester
1Department of Medical Education, Geisinger Commonwealth School of Medicine, Scranton, PA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Neal K. Bharati
1Department of Medical Education, Geisinger Commonwealth School of Medicine, Scranton, PA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
leTausjua B. Eley
1Department of Medical Education, Geisinger Commonwealth School of Medicine, Scranton, PA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephanie D. Nichols
2Department of Pharmacy Practice, University of New England, Portland, ME, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kenneth McCall
3Department of Pharmacy Practice, Binghamton University, Binghamton, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brian J. Piper
1Department of Medical Education, Geisinger Commonwealth School of Medicine, Scranton, PA, USA
4Center for Pharmacy Innovation and Outcomes, Geisinger Precision Heath Center, Forty Fort, PA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Brian J. Piper
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Purpose Opioid overdose remains a problem in the United States despite pharmacotherapies, such as buprenorphine, in the treatment of opioid use disorder (OUD). This study characterized changes in buprenorphine use.

Methods Using the Drug Enforcement Administration’s ARCOS, Medicaid and Medicare claims databases, patterns in buprenorphine usage in the United States from 2018 to 2020 were analyzed by examining percentage changes in total grams distributed and changes in grams per 100K people in year-to-year usage based on zip-code and state levels.

Results For ARCOS from 2018-19 and 2019-20, total buprenorphine distribution in grams increased 16.2% and 12.6% respectively. South Dakota showed the largest state-wide percentage increase in both 2018-19 (66.1%) and 2019-20 (36.7%). From 2018-19, the zip codes ND-577 (156.4%) and VA-222 (−82.1%) had the largest and smallest percentage changes respectively. From 2019-20, CA-932 (250.2%) and IL-603 (−36.8%) were the largest and smallest respectively. In both 2018-19 and 2019-20, PA-191 had the second highest increase in grams per 100K while OH-452 was the only zip code to remain in the top 3 largest decreases in grams per 100K in both periods. Among Medicaid patients in 2018, there was a 1,932.1-fold difference in prescriptions per 100k Medicaid enrollees between Kentucky (12,075.5) and Nebraska (6.25). Among Medicare enrollees in 2018, family medicine physicians and other primary care providers were the top buprenorphine prescribers.

Conclusions This study identified overall increases in buprenorphine availability but also pronounced state-level differences. Such geographic analysis can be used to discern which public policies and regional factors impact buprenorphine access.

Key Points

  • Total buprenorphine distribution in grams increased 16.2% and 12.6% for 2018-2019 and 2019-2020 ARCOS data, respectively

  • On a state level, from 2020-21, the majority of states were decreasing buprenorphine distribution as reported by ARCOS

  • The state with the highest buprenorphine usage among Medicaid patients in both 2018 and 2019 was Kentucky

  • Family medicine physicians were the top buprenorphine prescribers to Medicare enrollees in 30 states

  • Maine had the largest number of buprenorphine prescriptions to Medicare enrollees

Plain Language Summary Opioid overdose remains a problem in the United States despite medical therapy, such as buprenorphine, in the treatment of opioid use disorder (OUD). This study aimed to describe changes in buprenorphine use. Using the Drug Enforcement Administration’s ARCOS, Medicare, and Medicaid databases, patterns in buprenorphine usage in the United States from 2018 to 2020 were analyzed based on zip-code and state levels. For ARCOS from 2018-19 and 2019-20, total buprenorphine distribution in grams increased 16.2% and 12.6% respectively.South Dakota showed the largest state-wide percentage increase in both 2018-19 (66.1%) and 2019-20 (36.7%). From 2018-19, the zip codes ND-577 (156.4%) and VA-222 (−82.1%) had the largest and smallest percentage changes respectively. From 2019-20, CA-932 (250.2%) and IL-603 (−36.8%) were the largest and smallest respectively. Among Medicaid patients in 2018, there was a 1,932.1-fold difference in prescriptions per 100k Medicaid enrollees between Kentucky (12,075.5) and Nebraska (6.25). Among Medicare enrollees in 2018, family medicine physicians and other primary care providers were the top buprenorphine prescribers. This study found overall increases in buprenorphine availability but also pronounced state-level differences. Such geographic analysis can be used to determine which public policies and regional factors impact access to buprenorphine.

Ethics Statement Hereby, I Justina A. Warnick consciously assure that for the manuscript “An Analysis of Patterns of Distribution of Buprenorphine in the United States using ARCOS, Medicaid, and Medicare Databases” the following is fulfilled:

  1. This material is the authors’ own original work, which has not been previously published elsewhere aside from preprint server MedRxiv.

  2. The paper is not currently being considered for publication elsewhere.

  3. The paper reflects the authors’ own research and analysis in a truthful and complete manner.

  4. The paper properly credits the meaningful contributions of co-authors and co-researchers.

  5. The results are appropriately placed in the context of prior and existing research.

  6. All sources used are properly disclosed (correct citation). Literally copying of text must be indicated as such by using quotation marks and giving proper reference.

  7. All authors have been personally and actively involved in substantial work leading to the paper and will take public responsibility for its content.

I acknowledge that the violation of the Ethical Statement rules may result in severe consequences.

Figure
  • Download figure
  • Open in new tab

Competing Interest Statement

BJP was (2019-2021) part of an osteoarthritis research team supported by Pfizer and Eli Lilly.

Funding Statement

This study did not receive any funding

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

ARCOS, Medicaid, and Medicare databases

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Prior Presentations: The findings from this manuscript have been previously presented in poster format at the Geisinger Commonwealth School of Medicine Spring Student Research Symposium in Scranton, PA in April 2021. A preprint was submitted to MedRxiv on 8/22/2022.

Data Availability

All data produced in the present study are available upon reasonable request to the authors

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted August 23, 2022.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
An Analysis of Patterns of Distribution of Buprenorphine in the United States using ARCOS, Medicaid, and Medicare Databases
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
An Analysis of Patterns of Distribution of Buprenorphine in the United States using ARCOS, Medicaid, and Medicare Databases
Zhi-Shan Hsu, Justina A. Warnick, Tice R. Harkins, Briana E. Sylvester, Neal K. Bharati, leTausjua B. Eley, Stephanie D. Nichols, Kenneth McCall, Brian J. Piper
medRxiv 2022.08.22.22279092; doi: https://doi.org/10.1101/2022.08.22.22279092
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
An Analysis of Patterns of Distribution of Buprenorphine in the United States using ARCOS, Medicaid, and Medicare Databases
Zhi-Shan Hsu, Justina A. Warnick, Tice R. Harkins, Briana E. Sylvester, Neal K. Bharati, leTausjua B. Eley, Stephanie D. Nichols, Kenneth McCall, Brian J. Piper
medRxiv 2022.08.22.22279092; doi: https://doi.org/10.1101/2022.08.22.22279092

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Addiction Medicine
Subject Areas
All Articles
  • Addiction Medicine (430)
  • Allergy and Immunology (756)
  • Anesthesia (221)
  • Cardiovascular Medicine (3292)
  • Dentistry and Oral Medicine (364)
  • Dermatology (279)
  • Emergency Medicine (479)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1171)
  • Epidemiology (13374)
  • Forensic Medicine (19)
  • Gastroenterology (899)
  • Genetic and Genomic Medicine (5153)
  • Geriatric Medicine (482)
  • Health Economics (783)
  • Health Informatics (3268)
  • Health Policy (1140)
  • Health Systems and Quality Improvement (1190)
  • Hematology (431)
  • HIV/AIDS (1017)
  • Infectious Diseases (except HIV/AIDS) (14627)
  • Intensive Care and Critical Care Medicine (913)
  • Medical Education (477)
  • Medical Ethics (127)
  • Nephrology (523)
  • Neurology (4925)
  • Nursing (262)
  • Nutrition (730)
  • Obstetrics and Gynecology (883)
  • Occupational and Environmental Health (795)
  • Oncology (2524)
  • Ophthalmology (724)
  • Orthopedics (281)
  • Otolaryngology (347)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (543)
  • Pediatrics (1302)
  • Pharmacology and Therapeutics (550)
  • Primary Care Research (557)
  • Psychiatry and Clinical Psychology (4212)
  • Public and Global Health (7504)
  • Radiology and Imaging (1705)
  • Rehabilitation Medicine and Physical Therapy (1013)
  • Respiratory Medicine (980)
  • Rheumatology (480)
  • Sexual and Reproductive Health (497)
  • Sports Medicine (424)
  • Surgery (548)
  • Toxicology (72)
  • Transplantation (236)
  • Urology (205)